Dr. Sulaiman Al Habib Medical Services Group Company

SASE:4013 Stock Report

Market Cap: ر.س99.7b

Dr. Sulaiman Al Habib Medical Services Group Future Growth

Future criteria checks 4/6

Dr. Sulaiman Al Habib Medical Services Group is forecast to grow earnings and revenue by 15.1% and 14.2% per annum respectively. EPS is expected to grow by 14.6% per annum. Return on equity is forecast to be 40.2% in 3 years.

Key information

15.1%

Earnings growth rate

14.6%

EPS growth rate

Healthcare earnings growth15.5%
Revenue growth rate14.2%
Future return on equity40.2%
Analyst coverage

Good

Last updated13 Dec 2024

Recent future growth updates

Dr. Sulaiman Al Habib Medical Services Group Company Just Recorded A 9.6% Revenue Beat: Here's What Analysts Think

Nov 06
Dr. Sulaiman Al Habib Medical Services Group Company Just Recorded A 9.6% Revenue Beat: Here's What Analysts Think

Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

May 03
Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Recent updates

Risks To Shareholder Returns Are Elevated At These Prices For Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)

Dec 03
Risks To Shareholder Returns Are Elevated At These Prices For Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013)

Solid Earnings May Not Tell The Whole Story For Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013)

Nov 11
Solid Earnings May Not Tell The Whole Story For Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013)

Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Paying Out A Larger Dividend Than Last Year

Nov 07
Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Is Paying Out A Larger Dividend Than Last Year

Dr. Sulaiman Al Habib Medical Services Group Company Just Recorded A 9.6% Revenue Beat: Here's What Analysts Think

Nov 06
Dr. Sulaiman Al Habib Medical Services Group Company Just Recorded A 9.6% Revenue Beat: Here's What Analysts Think

Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Ticks All The Boxes When It Comes To Earnings Growth

Oct 17
Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Ticks All The Boxes When It Comes To Earnings Growth

Investors Will Want Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Growth In ROCE To Persist

Jul 04
Investors Will Want Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Growth In ROCE To Persist

Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year

May 23
Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Shareholders Will Receive A Bigger Dividend Than Last Year

Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

May 08
Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of

Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

May 03
Dr. Sulaiman Al Habib Medical Services Group Company (TADAWUL:4013) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates

Subdued Growth No Barrier To Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price

Apr 29
Subdued Growth No Barrier To Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price

There's Been No Shortage Of Growth Recently For Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital

Mar 15
There's Been No Shortage Of Growth Recently For Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Returns On Capital

Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Dividend Will Be SAR1.15

Feb 22
Dr. Sulaiman Al Habib Medical Services Group's (TADAWUL:4013) Dividend Will Be SAR1.15

With EPS Growth And More, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Makes An Interesting Case

Feb 20
With EPS Growth And More, Dr. Sulaiman Al Habib Medical Services Group (TADAWUL:4013) Makes An Interesting Case

Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price Is Out Of Tune With Earnings

Jan 09
Dr. Sulaiman Al Habib Medical Services Group Company's (TADAWUL:4013) Price Is Out Of Tune With Earnings

Earnings and Revenue Growth Forecasts

SASE:4013 - Analysts future estimates and past financials data (SAR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202615,8223,2832,7674,1659
12/31/202513,5382,6891,1683,4429
12/31/202411,1442,231-1,0102,7506
9/30/202410,5582,227-6133,058N/A
6/30/202410,0242,176-1,0463,031N/A
3/31/20249,7232,108-7583,291N/A
12/31/20239,5082,046-2533,244N/A
9/30/20239,2761,962603,072N/A
6/30/20238,8851,8385092,789N/A
3/31/20238,6271,7501,2192,932N/A
12/31/20228,3111,6511,3302,844N/A
9/30/20228,0251,5938382,411N/A
6/30/20227,8091,5219562,254N/A
3/31/20227,5471,4481,0672,419N/A
12/31/20217,2501,3779292,183N/A
9/30/20216,9741,3111,1562,441N/A
6/30/20216,7611,2611,1202,170N/A
3/31/20216,2131,1281,2192,183N/A
12/31/20205,8621,0551,4202,234N/A
9/30/20205,5751,0081,2191,871N/A
6/30/20205,1789071,0301,743N/A
3/31/20205,1328835031,155N/A
12/31/20195,0168703261,059N/A
9/30/20194,8168258431,549N/A
6/30/20194,7358357531,539N/A
3/31/20194,6468191,0051,760N/A
12/31/20184,5888017891,447N/A
12/31/20174,687658N/A1,058N/A
12/31/20164,8681,010N/A900N/A
12/31/20155,1231,329N/A922N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 4013's forecast earnings growth (15.1% per year) is above the savings rate (14.7%).

Earnings vs Market: 4013's earnings (15.1% per year) are forecast to grow faster than the SA market (6% per year).

High Growth Earnings: 4013's earnings are forecast to grow, but not significantly.

Revenue vs Market: 4013's revenue (14.2% per year) is forecast to grow faster than the SA market (-0.5% per year).

High Growth Revenue: 4013's revenue (14.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 4013's Return on Equity is forecast to be very high in 3 years time (40.2%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 17:05
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dr. Sulaiman Al Habib Medical Services Group Company is covered by 18 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jassim Al-JubranAljazira Capital Company
Madhu AppissaAl Rajhi Capital
Christine KalindjianArqaam Capital Research Offshore S.A.L.